DM
Therapeutic Areas
Curatis Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| C-PTBE-01 (corticorelin) | Peritumoral Brain Edema (PTBE) | Phase 3 |
| C-AM-01 | Prevention of Severe Migraine with Aura | Phase 2 |
| C-MOH-01 | Treatment and Prevention of Medication Overuse Headache | Phase 2 |
| C-FI-01 | Fibrotic or Inflammatory Orphan/Ultra-Orphan Diseases | Preclinical/Proof-of-Concept |
Leadership Team at Curatis Pharma
GG
Günter Graubach
Founder, Executive Board Member, Chief Corporate Development Officer (CCDO)
DR
Dr. Roland Rutschmann
Executive Board Member, Chief Executive Officer (CEO)
DS
Dr. Silvio Inderbitzin
Non-Executive Member of the Board of Directors